This study is designed for adults with Moderate to sever AD whose disease cannot be adequately controlled with topical medications of for whom topical treatment is inadvisable (intolerance, etc) Requires subjects have had chronic AD for at least three (3) years, effecting at least 10% of body surface. Must have documented inadequate response to a prior therapy (can mean failure to achieve and maintain a low disease state despite treatment with a daily regimen of TCS). If a subject required systemic treatment in the last six (6) months, that is also considered in adequate response. Study agent is dupilumab, a fully-human monoclonal antibody. Fewer side effects than most other monoclonal drugs (primary complaint = cold like symptoms). Responders to medication may continue into one or two extension studies, meaning total treatment time could be two years +/-. A Phase 3 Placebo controlled Study Investigating the Efficacy and Safety of Multiple Dupilumab Dose. Regimens Administered as Monotherapy for maintaining Treatment Response in Patients with AD. Most study participants receive stipend for each visit completed, in addition to safety assessments (labs, EKGs, Physician exams, etc)

© 2018 Hillcrest Clinics. All Rights Reserved. | Privacy Statement
If you have a concern regarding the quality of care you received during your treatment at any one of the Hillcrest Clinics, or simply want to discuss an experience you may have had, please call our dedicated Patient Relations phone number at (254) 202-9680 Monday through Friday 8:00am-5:00pm.

To register a complaint about any provider or clinic with the Texas Medical Board, please click on the following link: Texas Medical Board.

The Hillcrest Clinics Websites are wholly owned and operated by HFHC (Hillcrest Family Health Centers). The websites, email your doctor, and the Hillcrest Clinics Patient Portal are for NON-EMERGENCY USE ONLY. Please allow up to 48 hours for a reply when using “Email Your Doctor” or the “Hillcrest Clinics Patient Portal”.
If you are experiencing an emergency, please call 9-1-1 or go to your nearest emergency room.